GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer
Condition: Advanced Endometrial Cancer Interventions: Drug: Pembrolizumab; Biological: GEN1046 Sponsors: Genmab; BioNTech SE Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
Conditions: Ovarian Cancer; Malignant Neoplasm of Uterus Interventions: Drug: Sacituzumab; Drug: Cisplatin Sponsor: Icahn School of Medicine at Mount Sinai Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials